These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

44 related items for PubMed ID: 11466586

  • 21. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH, Wildschiødtz G, Juul A, Hilsted J.
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [Abstract] [Full Text] [Related]

  • 22. Opioid dysregulation after biliopancreatic diversion: effect of naloxone on preprandial and postprandial growth hormone (GH)-releasing hormone-induced GH release in surgically induced weight loss.
    Mancini A, Bianchi A, Tacchino RM, Perrelli M, Milardi D, Gentilella R, Giampietro A, Fusco A, Valle D, De Marinis L.
    Metabolism; 2001 Apr; 50(4):382-6. PubMed ID: 11288030
    [Abstract] [Full Text] [Related]

  • 23. Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test.
    Maccario M, Gauna C, Procopio M, Di Vito L, Rossetto R, Oleandri SE, Grottoli S, Ganzaroli C, Aimaretti G, Ghigo E.
    J Endocrinol Invest; 1999 Jun; 22(6):424-9. PubMed ID: 10435851
    [Abstract] [Full Text] [Related]

  • 24. Effects of free fatty acids and acipimox, a lipolysis inhibitor, on the somatotroph responsiveness to GHRH in anorexia nervosa.
    Gianotti L, Fassino S, Daga GA, Lanfranco F, De Bacco C, Ramunni J, Arvat E, MacCario M, Ghigo E.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):713-20. PubMed ID: 10848875
    [Abstract] [Full Text] [Related]

  • 25. The inhibitory effect of glucose on growth hormone secretion is lost in obesity but not in hypertension.
    Limone P, Oleandri SE, Ajmone Catt P, Grottoli S, Frangioni C, Avogadri E, Perrin M, Valetto MR, Maccario M.
    J Endocrinol Invest; 1997 Nov; 20(10):616-20. PubMed ID: 9438920
    [Abstract] [Full Text] [Related]

  • 26. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
    Broglio F, Fubini A, Morello M, Arvat E, Aimaretti G, Gianotti L, Boghen MF, Deghenghi R, Mangiardi L, Ghigo E.
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):417-30. PubMed ID: 10468900
    [Abstract] [Full Text] [Related]

  • 27. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome.
    Gianotti L, Pivetti S, Lanfranco F, Tassone F, Navone F, Vittori E, Rossetto R, Gauna C, Destefanis S, Grottoli S, De Giorgi R, Gai V, Ghigo E, Maccario M.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5052-7. PubMed ID: 12414871
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.
    Maccario M, Grottoli S, Razzore P, Procopio M, Oleandri SE, Ciccarelli E, Camanni F, Ghigo E.
    Eur J Endocrinol; 1996 Aug; 135(2):205-10. PubMed ID: 8810734
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity.
    Tassone F, Grottoli S, Rossetto R, Maccagno B, Gauna C, Giordano R, Ghigo E, Maccario M.
    J Endocrinol Invest; 2002 Jun; 25(6):551-6. PubMed ID: 12109628
    [Abstract] [Full Text] [Related]

  • 32. Radionuclide angiocardiographic evaluation of the cardiovascular effects of recombinant human IGF-I in normal adults.
    Bisi G, Podio V, Valetto MR, Broglio F, Bertuccio G, DEl Rio G, Boghen MF, Berti F, Muller EE, Ghigo E.
    Eur J Endocrinol; 1999 Apr; 140(4):322-7. PubMed ID: 10097251
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of IGF-I administration on growth hormone secretion in obese subjects.
    Tassone F, Gianotti L, Lanfranco F, Ganzaroli C, Oleandri SE, Taliano M, Muller EE, Ghigo E, Maccario M.
    Int J Obes Relat Metab Disord; 2001 May; 25 Suppl 1():S41-2. PubMed ID: 11466586
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
    Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli G, Rossetto R, Wu Z, Strasburger CJ, Ghigo E.
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.